QCP Capital has reinvested in the decentralised exchange protocol developer, which also counts Binance and Bitlink Capital as existing backers.

Injective Protocol, the US-based developer of a decentralised exchange protocol, has secured $10m of new funding from investors including digital asset trading firm QCP Capital, The Block has reported.

The capital was raised through a private placement token sale also backed by Pantera Capital, BlockTower, Hashed Ventures, CMS Holdings and private investor Mark Cuban.

Founded in 2018, Injective Protocol has developed a decentralised exchange protocol that enables investors to trade digital assets including cryptocurrencies, non-fungible tokens and stocks across different…